NCT00091416View on ClinicalTrials.gov

Safety of and Immune Response to an HIV-1 Vaccine Boost (VRC-HIVADV014-00-VP) in HIV Uninfected Adults Who Participated in HVTN 052

PHASE1CompletedINTERVENTIONAL
Enrollment

70

Participants

Timeline

Start Date

Not specified

Study Completion Date

May 31, 2006

Conditions
HIV Infections
Interventions
BIOLOGICAL

VRC-HIVADV014-00-VP

Trial Locations (8)

37232

Vanderbilt Vaccine CRS, Nashville

98104

FHCRC/UW Vaccine CRS, Seattle

21205-1901

Johns Hopkins Bloomberg School of Public Health,Ctr for Immunization Research,Project SAVE-Baltimore, Baltimore

02115

Fenway Community Health Clinical Research Site (FCHCRS), Boston

63110-2500

Saint Louis Univ. School of Medicine, HVTU, St Louis

Unknown

HIV Prevention & Treatment CRS, New York

14642-0001

Univ. of Rochester HVTN CRS, Rochester

02906

Miriam Hospital's HVTU, Providence

All Listed Sponsors
lead

National Institute of Allergy and Infectious Diseases (NIAID)

NIH

NCT00091416 - Safety of and Immune Response to an HIV-1 Vaccine Boost (VRC-HIVADV014-00-VP) in HIV Uninfected Adults Who Participated in HVTN 052 | Biotech Hunter | Biotech Hunter